Abbreviations:
ADAMTS5, A disintegrin and metalloproteinase with thrombospondin motifs
5; APOC3, apolipoprotein C-III; AUC, area under the curve; BMI, body
mass index; CD99, CD99 antigen; CE-MS, capillary electrophoresis coupled
to mass spectrometry; COL1A1, collagen alpha-1(I) chain; COL1A2,
collagen alpha-2(I) chain; COL3A1, collagen alpha-1(III) chain; CRNN,
Cornulin; CPSF6, cleavage and polyadenylation specificity factor subunit
6; eGFR, estimated glomerular filtration rate; FDR, false discovery
rates; GLP-1R, Glucagon-like peptide-1 receptor; HbA1C, Hemoglobin A1C;
HBA, hemoglobin subunit alpha; KEGG, Kyoto Encyclopedia of Genes and
Genomes; MB, myoglobin; MMP, matrix metalloproteinase proteases; PIGR,
polymeric immunoglobulin receptor; PROVALID, Prospective Cohort Study in
Patients with T2DM for Validation of Biomarkers study; SBP/DBP,
systolic/diastolic blood pressure SERPINA1, alpha-1-antitrypsin;
SERPINA6, corticosteroid-binding globulin; T2DM, Type II diabetes
mellitus; TTR, transthyretin; VGF, neurosecretory protein VGF
Keywords: CE-MS, GLP-1R agonists, peptidomics, T2DM,
urine biomarker